EDWARDS LIFESCIENCES CORP
10-Q, EX-27.6, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: EDWARDS LIFESCIENCES CORP, 10-Q, EX-10.25, 2000-11-14
Next: INTECHNOLOGIES INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM EDWARDS
LIFESCIENCES CONSOLIDATED CONDENSED BALANCE SHEET AT SEPTEMBER 30, 2000,
CONSOLIDATED CONDENSED STATEMENT OF INCOME FOR THE THREE MONTHS ENDED SEPTEMBER
30, 2000 AND CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS FOR THE NINE MONTHS
ENDED SEPTEMBER 30 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                              13
<SECURITIES>                                         0
<RECEIVABLES>                                      154
<ALLOWANCES>                                         0
<INVENTORY>                                         78
<CURRENT-ASSETS>                                   277
<PP&E>                                             177
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,106
<CURRENT-LIABILITIES>                              277
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            59
<OTHER-SE>                                         365
<TOTAL-LIABILITY-AND-EQUITY>                     1,106
<SALES>                                            186
<TOTAL-REVENUES>                                   186
<CGS>                                               96
<TOTAL-COSTS>                                      169
<OTHER-EXPENSES>                                     2
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   8
<INCOME-PRETAX>                                      7
<INCOME-TAX>                                         3
<INCOME-CONTINUING>                                  4
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         4
<EPS-BASIC>                                       0.08
<EPS-DILUTED>                                     0.07


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission